clock menu more-arrow no yes mobile

Filed under:

Azunna Anyanwu accepts one-year suspension for USADA test failure

MMA: UFC Fight Night-Pittsburgh- Ledget vs Anyanwu
Azunna Anyanwu
Don Wright-USA TODAY Sports

Following an October 2017 drug test failure, UFC heavyweight Azunna Anyanwu has accepted a one-year suspension from the United States Anti-Doping Agency.

The USADA made the announcement Friday.

Anyanwu, 36, tested positive for furosemide in an out-of-competition test administered on Oct. 18, 2017, one month after he made his UFC debut in a split-decision loss to Justin Ledet. According to the USADA press release, furosemide is a “a Specified Substance in the class of Diuretics and Masking Agents and prohibited at all times.”

Prior to signing with the UFC, Anyanwu compiled a 14-4 record including a second-round knockout of Greg Rebello on Dana White’s Tuesday Night Contender Series. He would not be offered a contract, but was later called in on less than a week’s notice as an injury replacement to fight Ledet.

Anyanwu will be eligible to compete again on Oct. 18, 2018.

Sign up for the newsletter Sign up for the MMA Fighting Daily Roundup newsletter!

A daily roundup of all your fighting news from MMA Fighting